A bioinformatics approach combined with experimental validation analyzes the efficacy of azithromycin in treating SARS-CoV-2 infection in patients with IPF and COPD

Abstract The swift transmission rate and unfavorable prognosis associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have prompted the pursuit of more effective therapeutic interventions. Azithromycin (AZM) has garnered significant attention for its distinctive pharmacological...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yining Xie, Guangshu Chen, Weiling Wu, Xueman Wen, Meizheng Lai, Li Che, Jianmin Ran
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2025-03-01
coleção:	Scientific Reports
Assuntos:	COPD IPF SARS-Cov-2 Azithromycin Bioinformatics
Acesso em linha:	https://doi.org/10.1038/s41598-025-94801-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!